The Paul Ehrlich Institute has issued the first approval for clinical trials of a possible vaccine against the new SARS-CoV-2 coronavirus, DW reported.
He received the company Biontech from Mainz, which will now test the effect of the vaccine on volunteers.
Detained opposition Prosperous Armenia Party chairman, businessman Gagik Tsarukyan: You can't keep a country with charity
Ranking of world's largest agricultural economies announced
Netanyahu confirms disagreements with Trump over Hamas deal
UKMTO: Cargo ship hit by unidentified projectile off Oman coast
Hetq.am: TRIPP+ fund funds double, reaching $402M
Zelenskyy speaks about Armenia, Azerbaijan
make preferable
